NCT03246815

Brief Summary

National guidelines have recommended routine STD screening (chlamydia and gonorrhea) for sexually active young women under the age of 25. Despite these recommendations, many young women are not being screened for STDs, with some estimates that less than 50% of women receiving health care are screened for chlamydia. Untreated STDs can lead to important sequelae to women's reproductive health including pelvic inflammatory disease, infertility and ectopic pregnancy. One of the most important barriers to widespread STD screening is provider failure to recognize an opportunity for STD screening. The goal of this study is to determine whether offering STD screening (chlamydia and gonorrhea) by a non-physician member of the medical practice (who receives an automated alert indicating STD screening should be offered) will be associated with a higher rate of STD screening in young women attending primary care practices compared to usual care (where a physician offers screening with no electronic alert). This study will be performed in UPMC-affiliated primary care practices (Family Practice, Internal Medicine, OB/GYN, Pediatrics). Practices will be assigned to the intervention or usual care. The intervention will be an auto-task in the electronic medical record to the non-physician/NP/PA medical staff (medical assistants, LPNs, RNs) to offer chlamydia and gonorrhea screening via urine or self-collected vaginal sampling, in an opt-out manner, to eligible women. Practices assigned to the usual care group will not have the intervention. STD screening rates (# women undergoing STD screening/# eligible women) will be compared between the to groups (intervention practices and control practices). Results of this study may be important to guide national STD screening recommendations and will address critical barriers to widespread STD screening.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,771

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 12, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 18, 2017

Completed
24 days until next milestone

First Posted

Study publicly available on registry

August 11, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2019

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

March 10, 2021

Status Verified

March 1, 2021

Enrollment Period

2.4 years

First QC Date

July 18, 2017

Last Update Submit

March 9, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Rate of STD Screening

    Rate of screening (Chlamydia and Gonorrhea) in young women attending primary care practices

    Day 1

  • Number of Chlamydia and Gonorrhea infections identified

    Day 1

Study Arms (2)

universal opt-out screening for STDs

Patients who present to primary care practices who employee a universal opt-out strategy to medical assistants or nurses

without universal opt-out screening for STDs

Patients who present to primary care practices who do not employee a universal opt-out strategy to medical assistants or nurses

Eligibility Criteria

Age15 Years - 24 Years
Sexfemale(Gender-based eligibility)
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Young women at risk for STDs

You may qualify if:

  • Women ages 15-24 Sexually Active Receiving care in one of the primary care offices affiliated with UPMC selected for this study.

You may not qualify if:

  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Magee-Womens Hospital of UPMC/associated community clinics

Pittsburgh, Pennsylvania, 15213, United States

Location

Study Officials

  • Harold C Wiesenfeld, MD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 18, 2017

First Posted

August 11, 2017

Study Start

June 12, 2017

Primary Completion

November 11, 2019

Study Completion

December 30, 2020

Last Updated

March 10, 2021

Record last verified: 2021-03

Locations